The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis

Clinical Rheumatology

Volumn 28, Issue 4, 2009, Pages 397-402

  Tarner, Ingo H ^a   Müller Ladner, Ulf ^a   Uhlemann, Christine ^b   Lange, Uwe ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Ankylosing spondylitis; Balneotherapy; Hyperthermia; Proinflammatory cytokines

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORE TEMPERATURE; HUMAN; HYPERTHERMIC THERAPY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; HYPERTHERMIA, INDUCED; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; PILOT PROJECTS; SPONDYLITIS, ANKYLOSING; TEMPERATURE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61549091860     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-1059-x     Document Type: Article

References (37)

1. Panush RS (2000) American College of Rheumatology position statement: complementary and alternative therapies for rheumatic disease. Rheum Dis Clin North Am 26:189-192
2. Hentschel HD, Nold F, Regehr I (1969) Beobachtungen bei der Überwärmungstherapie der ankylosierenden Spondylitis. Verh Dtsch Ges Rheumatol 1:184-188
3. Bühring M, Bork-Wölwer L, Krippner H, Pirlet K (1977) Quantitative Veränderungen peripherer T-Lymphozyten unter Hyperthermie. MMW Münch Med Wochenschr 119:1591-1594
4. Bühring M, Bork-Wölwer L, Krippner H (1978) Peripheral T lymphocytopenia under exogenous thermal stress. Cancer 42:2794-2797
5. Schmidt KL (1987) Hyperthermie und Fieber. Wirkungen bei Mensch und Tier. Klinik, Pathologie, Immunologie, Wirkungen auf Entzündungen. Hippokrates Verlag, Stuttgart
6. Schmidt KL, Simon E (2001) Thermotherapy of pain, trauma and inflammatory and degenerative rheumatic diseases. In: Kosaka M, Sugahara T, Schmidt KL, Simon E (eds) Thermotherapy for neoplasia, inflammation, and pain. Springer, Tokyo, pp 527-539
7. Schmidt KL (2004) Zur Wirkung der Ganzkörperhyperthermie auf Entzündungen und Immunreaktionen: Experimentelle Grundlagen. Phys Rehab Kur Med 14:1-9
8. Schleenbecker H, Schmidt KL (1998) Zur Wirkung einer iterativen milden Ganzkörper-Hyperthermie auf den Fibromyalgieschmerz. Phys Rehab Kur Med 8:113-117
9. Hori T, Kaizuka Y, Takaki A, Katafuchi T (2001) Thermal stress and immunity. In: Kosaka M, Sugahara T, Schmidt KL, Simon E (eds) Thermotherapy for neoplasia, inflammation, and pain. Springer, Tokyo, pp 242-251
10. Lange U, Thielen G, Neeck G, Schmidt KL (2005) Einfluss der milden Hyperthermie auf die Blutspiegel von Kortisol und Lymphozytensubpopulationen bei Patienten mit ankylosierender Spondylitis und Gesunden. Phys Med Rehab Kuror 15:44-47
11. Braun J (2002) Stadiensystem radiographischer Einteilung. In: Braun J, Sieper J (eds) Spondylitis ankylosans. Uni-Med, Bremen, p 114
12. Sobieska M, Stratz T, Samborski W et al (1993) Interleukin-6 (IL-6) after whole body cryotherapy and local hot mud pack treatment [letter]. Eur J Phys Med Rehabil 3:205
13. Olszewski WL, Grzelak I, Ziolkowska A, Engeset A (1989) Effect of local hyperthermia on lymph immune cells and lymphokines of normal human skin. J Surg Oncol 41:109-116
14. Bellometti S, Galzigna L (1998) Serum levels of a prostaglandin and a leukotriene after thermal mud pack therapy. J Investig Med 46:140-145
15. Yoshioka A, Miyachi Y, Imamura S et al (1989) Suppression of contact sensitivity by local hyperthermia treatment due to reduced Langerhans cell population in mice. Br J Dermatol 120:493-501
16. Huang YH, Haegerstrand A, Frostegård J (1996) Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 103:61-66
17. Shen RN, Hornback NB, Shidnia H et al (1991) Whole body hyperthermia: A potent radioprotector in vivo. Int J Radiat Oncol Biol Phys 20:525-530
18. Tütüncü ZN, Turan M, Yüzbasioglu N, Karagülle MZ (1996) Changes in TNFα plasma levels in osteoarthritis patients under balneotherapy with acratothermal water. Phys Rehab Kur Med 6:80-82
19. Tütüncü ZN, Bilgie A, Kennedy LG, Calin A (1994) Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis. Ann Rheum Dis 53:425-426
20. Gratacós J, Collado A, Filella X et al (1994) Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: A close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 33:927-931
21. Falkenbach A, Herold M (1998) In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility. Rheumatol Int 18:103-106
22. Gratacós J, Collado A, Pons F et al (1999) Significant loss of bone mass in patients with early, active ankylosing spondylitis: A followup study. Arthritis Rheum 42:2319-2324
23. Bal A, Unlu E, Bahar G et al (2007) Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26:211-215
24. Park MC, Lee SW, Choi ST et al (2007) Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 36:101-106
25. Brandt J, Haibel H, Cornely D et al (2000) Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43:1346-1352
26. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507-511
27. Chou CT, Huo AP, Chang HN et al (2007) Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives. Arch Med Res 38:190-195
28. François RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: Detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis 65:713-720
29. Vazquez-Del MM, Garcia-Gonzalez A, Muñoz-Valle JF et al (2002) Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis. J Rheumatol 29:522-526
30. Rudwaleit M, Siegert S, Yin Z et al (2001) Low T cell production of TNFα and IFNγ in ankylosing spondylitis: Its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60:36-42
31. Furst D, Breedveld FC, Kalden JR et al (2007) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis 66(Suppl III):iIi2-iii22
32. Maini RN, Taylor PC, Szechinski J, CHARISMA Study Group et al (2006) Double-blind, randomized controlled trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 54:2817-2829
33. Wendling D, Racadot E, Toussirot E, Wijdenes J (1996) Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy. Br J Rheumatol 35:1330
34. Toussirot E, Lafforgue P, Boucraut J et al (1994) Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies. Rheumatol Int 13:175-180
35. Tan AL, Marzo-Ortega H, O'Connor P et al (2004) Efficacy of anakinra in active ankylosing spondylitis: A clinical and magnetic resonance imaging study. Ann Rheum Dis 63:1041-1045
36. Haibel H, Rudwaleit M, Listing J, Sieper J (2005) Open label trial of anakinra in active ankylosing spondylitis over 24 weeks. Ann Rheum Dis 64:296-298
37. Bennett AN, Tan AL, Coates LC et al (2008) Sustained response to anakinra in ankylosing spondylitis. Rheumatology 47:223-224